Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-91,800
Closed -$200K 1363
2022
Q3
$200K Buy
+91,800
New +$317K ﹤0.01% 1192
2022
Q1
Sell
-77,100
Closed -$483K 1272
2021
Q4
$483K Sell
77,100
-34,100
-31% -$233K ﹤0.01% 1104
2021
Q3
$884K Sell
111,200
-174,900
-61% -$1.44M ﹤0.01% 1014
2021
Q2
$2.14M Buy
286,100
+103,300
+57% +$721K ﹤0.01% 767
2021
Q1
$1.11M Buy
182,800
+15,600
+9% +$120K ﹤0.01% 836
2020
Q4
$955K Buy
167,200
+16,800
+11% +$107K ﹤0.01% 861
2020
Q3
$1M Buy
+150,400
New +$1.34M ﹤0.01% 731

Other funds holding VXRT

IMC Chicago's VXRT Position: Q4 2021 in Review

IMC Chicago sold out of Vaxart (VXRT) in Q4 2021, closing a stake of 34,913 shares — an estimated $238K sold.

IMC Chicago first reported a position in VXRT in Q2 2021 and held it in 2 quarters. The position peaked at $278K in Q3 2021. 147 funds tracked by Wall St. Rank hold VXRT as of Q4 2021.

  • IMC Chicago reported no remaining Vaxart position as of Q4 2021 after selling out during the quarter.
  • IMC Chicago sold 34,913 Vaxart shares in Q4 2021, an estimated $238K.
  • IMC Chicago first reported a position in Vaxart in Q2 2021 and held it in 2 quarters.
  • IMC Chicago's Vaxart position peaked at $278K in Q3 2021.
  • 147 funds tracked by Wall St. Rank held Vaxart as of Q4 2021.

Based on IMC Chicago's 13F filing for Q4 2021, filed 8 Feb 2022.